Portage Biotech Inc (PRTG)

Currency in USD
6.0000
+0.3200(+5.63%)
Real-time Data·
PRTG Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
PRTG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.65006.4000
52 wk Range
2.098023.0100
Key Statistics
Prev. Close
5.6972
Open
5.65
Day's Range
5.65-6.4
52 wk Range
2.098-23.01
Volume
29.72K
Average Volume (3m)
109.31K
1-Year Change
44.5%
Book Value / Share
-0.07
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PRTG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Portage Biotech Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Portage Biotech Inc Company Profile

Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-8, a dual inhibitor of adenosine receptors 2A and 2B, which is in preclinical trial to treat solid tumors; PORT-6, a highly selective A2A receptor antagonist, which is in phase 1a for the treatment of solid tumors; PORT-7, a potent and selective antagonist of the adenosine A2B receptor; PORT-9, an A2B antagonist, which is in pre-clinical stage program to treat colorectal and gastrointestinal cancers; and PORT-3, a polylactide-co-glycolide, which is in phase 1 to treat NY-ESO-1 positive tumors. The company also develops PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; and PORT-5, a VLP-STING to treat of solid tumors and is in preclinical trials. Portage Biotech Inc. is based in Tortola, British Virgin Islands.

Compare PRTG to Peers and Sector

Metrics to compare
PRTG
Peers
Sector
Relationship
P/E Ratio
−2.0x−0.6x−0.5x
PEG Ratio
−0.020.000.00
Price/Book
−111.7x1.1x2.6x
Price / LTM Sales
-7.2x3.2x
Upside (Analyst Target)
-197.2%42.0%
Fair Value Upside
Unlock15.0%6.6%Unlock

Earnings

Latest Release
Jul 25, 2025
EPS / Forecast
-2.88 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

PRTG Income Statement

People Also Watch

1.03
KLTO
+7.29%
2.94
RBNE
-4.23%
2.73
INMB
-13.57%
0.830
WINT
+1.82%
6.1400
BGLC
+37.67%

FAQ

What Stock Exchange Does Portage Biotech Inc Trade On?

Portage Biotech Inc is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Portage Biotech Inc?

The stock symbol for Portage Biotech Inc is "PRTG."

What Is the Portage Biotech Inc Market Cap?

As of today, Portage Biotech Inc market cap is 13.66M.

What Is Portage Biotech Inc's Earnings Per Share (TTM)?

The Portage Biotech Inc EPS (TTM) is -5.72.

From a Technical Analysis Perspective, Is PRTG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Portage Biotech Inc Stock Split?

Portage Biotech Inc has split 2 times.

How Many Employees Does Portage Biotech Inc Have?

Portage Biotech Inc has 7 employees.

What is the current trading status of Portage Biotech Inc (PRTG)?

As of 30 Jul 2025, Portage Biotech Inc (PRTG) is trading at a price of 6.00, with a previous close of 5.70. The stock has fluctuated within a day range of 5.65 to 6.40, while its 52-week range spans from 2.10 to 23.01.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.